Hereditary hemorrhagic telangiectasia: A model for blood vessel growth and enlargement

American Journal of Pathology

Volumn 156, Issue 3, 2000, Pages 737-742

  Jacobson, Bruce S ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN;

ANGIOGENESIS; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; NONSENSE MUTATION; NOTE; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE;

EID: 0033889234     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64939-5     Document Type: Note

References (41)

1. Blood vessel formation: What is its molecular basis?
2. Heterogeneity of the angiogenic response induced in different normal adult tissues by VPFR/VEGF
3. Hereditary hemorrhagic telangiectasia
4. Hereditary hemorrhagic telangiectasia and pulmonary artiovenous malformations: Issues in clinical management and review of pathogenic mechanisms
5. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformation of patients with hereditary hemorrhagic telangiectasia type 1
6. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1
7. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies
8. Primary structure of endoglin, an RGD-containing glycoprotien of human endothelial cells
9. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells
10. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta
11. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily
12. The biphasic effects of transforming growth factors β in angiogenesis
13. TGF-beta and the endothelium during immune injury
14. TGF-beta signal transduction
15. Transforming growth factor-beta: Vasculogenesis, angiogenesis and vessel wall integrity
16. Supermodels and disease: Insights from the HHT mice
17. A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12
18. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors
19. Expression of ALK-1, a type 1 serine/threonine kinase receptor, conincides with sites of vasculogenesis and angiogenesis in early mouse development
20. Type I receptor serine-threonine kinase preferentially expressed in pulmonary blood vessels
21. Characterization of type I receptors for transforming growth factor-beta and activin
22. Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I receptors
23. Assignment of transforming growth factor beta-1 and beta-3 and a third new ligand to the type I receptor ALK-1
24. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative
25. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic type 1
26. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expressions and mutation analysis of endoglin
27. A murine model of hereditary hemorrhagic telangiectasia
28. Endoglin, an ancillary TGF receptor, is required for extra-embryonic angiogenesis, and plays a key role in heart development
29. Defective angiogeqesis in mice lacking endoglin
30. Schistosoma mansoni: Evidence that vascular abnormalities correlate with the 'non-permissive' trait in 129/Ola mice
31. Portal shunting and resistance to Schistosoma mansoni in 129 strain mice
32. Ultrastructure and three dimensional organization of the telegiectases of hereditary hemorrhagic telengiectasia
33. Tepmoral mapping of gene expression levels during the differentiation of individual primary hematopoietic cells
34. Loops, lineage, and leukemia
35. Positive and negative regulation of the myeloid dendritic cell lineage
36. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions
37. The intima: A new soil
38. Macro-and microvascular endothelial cells in vitro: Maintenance of biochemical heterogeneity despite loss of ultrastructural characteristics
39. The cardiovascular system
40. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization